CORTICOTROPIN-RELEASING FACTOR-SEROTONIN INTERACTIONS
促肾上腺皮质激素释放因子-血清素相互作用
基本信息
- 批准号:6994444
- 负责人:
- 金额:$ 53.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-04-01 至 2007-07-31
- 项目状态:已结题
- 来源:
- 关键词:afferent nerveautoradiographybrain mappingcorticotropin releasing factordepressiondorsal raphe nucleuselectron microscopyelectrophysiologyhormone regulation /control mechanismimmunocytochemistryin situ hybridizationlaboratory ratmicrodialysisneurochemistryneuropathologyneurotransmitter transportprosencephalonreceptor bindingreceptor expressionreceptor sensitivityserotoninstress
项目摘要
DESCRIPTION (provided by applicant): Corticotropin-releasing factor (CRF) and
the serotonergic (5-HT)-dorsal raphe nucleus (DRN) system have been
independently implicated in the acute response to stress and in stress-related
psychiatric disorders (e.g., anxiety, depression). During the last few years,
we provided evidence that these two systems are anatomically and functionally
linked in the response to stress. Thus, we demonstrated that CRF regulates DRN
neuronal activity and 5-HT release in forebrain targets in response to acute
stress. Moreover, we demonstrated that repeated stress results in
cross-adaptation of the DRN-5-HT system to CRF and subsequent stress. The
guiding hypothesis of this competing renewal is that CRF neuromodulation of the
DRN-5-HT system underlies certain components of the behavioral limb of the
acute stress response and that stress-induced plasticity in this function of
CRF underlies psychiatric symptoms associated with repeated or chronic stress.
The following AIMs integrate diverse approaches to test this hypothesis. AIM 1:
will use in vivo microdialysis and electrophysiology to elucidate specific
neuronal and neurochemical consequences of selectively activating CRF-R1 vs.
CRF-R2 receptors within the DRN. AIM 2: will identify the anatomical substrates
and circuitry by which CRF impacts on the DRN-5-HT system using
immunohistochemistry, in situ hybridization and electron microscopy. AIM 3:
will identify behavioral consequences of selectively activating CRF-R1 vs.
CRF-R2 receptors within the DRN. AIM 4: will examine stress-induced adaptation
of the DRN-5-HT system with regard to a) the role of CRF, b) the underlying
mechanisms and c) whether neurochemical adaptation is causal to behavioral
adaptation (using in vivo microdialysis, behavior and receptor
autoradiography). Our previous work introduced the innovative idea that
CRF-5-HT interactions are a pathophysiological focus of psychiatric disorders
and a target of novel psychotherapeutic agents. The proposed studies will
thoroughly characterize these interactions from a cellular to behavioral level.
As such, they will enhance our understanding of the role of stress in
psychopathology and indicate novel targets for the treatment of stress-related
psychiatric disorders.
性状(由申请人提供):促肾上腺皮质激素释放因子(CRF)和
多巴胺能(5-HT)-中缝背核(DRN)系统已经被
独立参与对压力的急性反应和与压力相关的
精神障碍(例如,焦虑、抑郁)。在过去的几年里,
我们提供的证据表明,这两个系统在解剖学和功能上
与压力反应有关。因此,我们证明了CRF调节DRN
急性脑损伤后前脑靶区神经元活动和5-HT释放的变化
应力此外,我们证明了重复的压力会导致
DRN-5-HT系统对CRF和随后的应激的交叉适应。的
这种竞争性更新的指导假设是,
DRN-5-HT系统是脑神经元行为肢某些成分的基础。
急性应激反应和应激诱导的可塑性在这一功能,
CRF是与反复或慢性压力相关的精神症状的基础。
以下目标整合了不同的方法来检验这一假设。目标1:
将使用体内微透析和电生理学来阐明特定的
选择性激活CRF-R1与
DRN内的CRF-R2受体。目的2:将识别解剖基质
以及CRF影响DRN-5-HT系统的电路,
免疫组织化学、原位杂交和电子显微镜。目标3:
将确定选择性激活CRF-R1与
DRN内的CRF-R2受体。目标4:将检查压力诱导的适应
DRN-5-HT系统的a)CRF的作用,B)
机制和c)神经化学适应是否是行为的因果关系
适应(使用体内微透析,行为和受体
放射自显影)。我们以前的工作介绍了创新的想法,
CRF-5-HT相互作用是精神疾病的病理生理学焦点
也是新型精神治疗药物的目标拟议的研究将
从细胞到行为水平彻底描述这些相互作用。
因此,它们将增强我们对压力在以下方面的作用的理解:
精神病理学,并指出新的目标,为治疗压力相关的
精神疾病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RITA VALENTINO其他文献
RITA VALENTINO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RITA VALENTINO', 18)}}的其他基金
Bladder Regulation by Corticotropin-Releasing Factor
促肾上腺皮质激素释放因子对膀胱的调节
- 批准号:
6964946 - 财政年份:2005
- 资助金额:
$ 53.1万 - 项目类别:
Bladder Regulation by Corticotropin-Releasing Factor
促肾上腺皮质激素释放因子对膀胱的调节
- 批准号:
7140376 - 财政年份:2005
- 资助金额:
$ 53.1万 - 项目类别:
CORTICOTROPIN RELEASING FACTOR/SEROTONERGIC INTERACTIONS
促肾上腺皮质激素释放因子/血清素相互作用
- 批准号:
2757947 - 财政年份:1998
- 资助金额:
$ 53.1万 - 项目类别:
BRAIN/PELVIC VISCERA INTERACTIONS IN PSYCHIATRIC DISEASE
精神疾病中大脑/盆腔内脏的相互作用
- 批准号:
2688701 - 财政年份:1998
- 资助金额:
$ 53.1万 - 项目类别:
相似海外基金
Harnessing PET to Study the In Vivo Fate and Health Effects of Micro- and Nanoplastics
利用 PET 研究微塑料和纳米塑料的体内命运和健康影响
- 批准号:
10890903 - 财政年份:2023
- 资助金额:
$ 53.1万 - 项目类别:
Altered microglia states and microglia-endothelial cell axis in relation to white matter disease progression in VCID
VCID 中小胶质细胞状态和小胶质细胞内皮细胞轴的改变与白质疾病进展相关
- 批准号:
10738860 - 财政年份:2023
- 资助金额:
$ 53.1万 - 项目类别:
Subtype-Selective Metabotropic Glutamate Receptor PET Ligands
亚型选择性代谢型谷氨酸受体 PET 配体
- 批准号:
10576674 - 财政年份:2023
- 资助金额:
$ 53.1万 - 项目类别:
Circadian Rhythms in Blood Brain Barrier Permeability and Increased Efficacy of Chemotherapy for Brain Metastases
血脑屏障通透性的昼夜节律和脑转移化疗疗效的提高
- 批准号:
10663717 - 财政年份:2023
- 资助金额:
$ 53.1万 - 项目类别:
Glycogen synthase kinase 3 ligand discovery for Alzheimer’s disease
糖原合成酶激酶 3 配体发现治疗阿尔茨海默病
- 批准号:
10637434 - 财政年份:2023
- 资助金额:
$ 53.1万 - 项目类别:
Assessing Diffusion MRI Metrics for Detecting Changes of Synaptic Density in Alzheimer's Disease
评估弥散 MRI 指标以检测阿尔茨海默病突触密度的变化
- 批准号:
10739911 - 财政年份:2023
- 资助金额:
$ 53.1万 - 项目类别:
Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers
支持在吸烟者 2 期临床研究中评估 mGlu2 PAM SBP-9330 的安全性/毒理学、ADME 和 CMC 活动
- 批准号:
10829189 - 财政年份:2023
- 资助金额:
$ 53.1万 - 项目类别:
Probing D2 and 5HT-2A mechanisms in early visual processing in V1
探索 V1 早期视觉处理中的 D2 和 5HT-2A 机制
- 批准号:
10605769 - 财政年份:2023
- 资助金额:
$ 53.1万 - 项目类别:
Develop in vivo PET imaging probes for ROCK2 as a biomarker of early Alzheimer's disease.
开发 ROCK2 的体内 PET 成像探针作为早期阿尔茨海默病的生物标志物。
- 批准号:
489145 - 财政年份:2023
- 资助金额:
$ 53.1万 - 项目类别:
Operating Grants














{{item.name}}会员




